Metropolis Healthcare (METROPOLIS) — Offer Document

📢 Key Event
Metropolis Healthcare held its Investor & Analyst Meet on August 27, 2026, outlining strategic growth plans.

🔄 What Changed
Revenue growth guidance of 14-15% for FY27, EBITDA margin target of 27-28%, and specialty tests to reach 45% of revenue by FY27.

🔮 What's Next
FY27 revenue growth guidance of 14-15% with no price increase, EBITDA margin expansion to 27-28%, and specialty tests to constitute ~45% of revenue.

💡 Investor Takeaway
The company is focused on scaling its network, expanding specialty testing, and driving margin improvement through automation and volume growth to deliver sustainable shareholder value.

Metropolis Healthcare announced its Investor & Analyst Meet on August 27, 2026, reaffirming its strategic vision to expand diagnostics through technology, specialty testing, and network growth. The presentation highlighted FY26 revenue of ₹1,646 crores, EBITDA of ₹401 crores, and PAT of ₹191 crores, with FY26 guidance targeting 14-15% revenue growth and EBITDA margin expansion to 27-28%. Key growth engines include network scaling to 1,000 stores, specialty tests rising to 45% of revenue, and TruHealth contributing 25% of revenue by FY27. The company emphasized volume-led growth, automation, and inorganic acquisitions via a proven playbook, supported by strong governance and promoter-led leadership.

📄 View Original Announcement (PDF)

📊 Stock Analysis — METROPOLIS ✨ Ask AI About This

About Metropolis Healthcare Ltd (METROPOLIS)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹12,082.27 Cr P/E: 25.0 ROE: 13.5% ROCE: 19.8% Div Yield: 0.86%

View full METROPOLIS stock details →

📡 Get AI alerts when METROPOLIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track METROPOLIS — Free

💡 Ask AI about this filing

"How will Metropolis achieve 45% specialty revenue share by FY27?" "What is the expected CAPEX allocation for network expansion to 1,000 stores?" "How does the company plan to maintain margins without price increases?"

Ask AI Free →

📊 More METROPOLIS filings

See all METROPOLIS filings →

🔥 Also filed on 27 August 2026

JNPR Juniper Green Energy Ltd Financial Results AWFIS AWFIS Space Solutions Ltd Annual Report 509084 Photon Capital Advisors Ltd Annual Report GUJALKALI Gujarat Alkalies & Chemicals Ltd Annual Report EPACK Epack Durable Ltd Annual Report 538546 Bansal Roofing Products Ltd Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when METROPOLIS files new disclosures

Track METROPOLIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track METROPOLIS — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd